“enanta-pharmaceuticals” Archives

in
Entry Author Date Location
East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More 04/28/16 Boston
With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets 04/13/16 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
Pharmabros, Designer Babies, And Other Final Words For 2015 12/24/15 National
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Hepatitis C Commercial Game Theory 01/01/15 National
Enanta Pockets $75M As AbbVie, Gilead Hep C Battle Begins 12/19/14 Boston
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
Merck Scoops Up Idenix in $3.85B Buyout 06/09/14 Boston
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Xconomy Boston’s Top Stories of Q1 2014: Editor’s Picks 03/31/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
Gilead Wins FDA Approval for Big Hepatitis C Drug 12/06/13 San Francisco
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More 09/06/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
U.S. Venture Activity Remains Steady as IPOs Rise in Second Quarter 07/16/13 National
Harvard Professor Steps Down to Pilot Warp Drive Bio 07/02/13 Boston
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
Enanta, Tetraphase Go Public in Boston Biotech IPO Madness 03/21/13 Boston
Enanta, Satori, Vertex & More of the Week’s Life Sciences Newsmakers 02/24/12 Boston
GreatPoint, Enanta, NextView, & More Boston Dealmakers 02/22/12 Boston
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News 05/20/09 Boston
Page 1 of 2 next page »